Medical Developments in Lexington Could Prove as Viable New Treatment for Type 2 Diabetes
Lexington based Fractyl Health secured $100 million as it looks to wrap up late-stage trials of a new minimally-invasive, endoscopic treatment for Type 2 diabetes. Read more information here.
0 Comments